Very Long-Term Prognosis in Patients with Hypertrophic Cardiomyopathy: A Longitudinal Study with a Period of 20 Years
Authors:
Open Access
- 2 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (4) , 2618-2625
Abstract
Aims: We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for a follow-up period of more than 10 years. Methods and results: We retrospectively analysed 102 consecutive patients with HCM diagnosed by 31 December 2000. Complete and detailed clinical records were obtained for 93 (91%) of the 102 patients. Sixty-three (68%) of the 93 patients were men, and the mean age of the patients at the initial evaluation was 51.5 ± 13.0 years. During the mean follow-up period of 19.6 ± 8.1 years (median 20.1 years), HCM-related deaths occurred in 20 patients (21% [1.1%/year]). HCM-related adverse events (including HCM-related deaths and nonfatal HCM-related events: hospitalization for heart failure, embolic stroke admission, and sustained ventricular tachycardia with haemodynamic instability or appropriate implantable cardioverter-defibrillator discharge) occurred in 45 patients (48%). The first HCM-related adverse events occurred in approximately 20% of the patients in every decade, the first decade to the third decade, from the initial evaluation. Forty-seven patients (51%) had documentation of atrial fibrillation at the last follow-up. There were seven patients in the end-stage HCM group at the initial evaluation, and 22 patients (24%) had progression to end-stage HCM during the follow-up period. Conclusions: In our cohort of patients, HCM-related mortality was relatively favourable. However, approximately half of the patients suffered from HCM-related adverse events during the follow-up period of 20 years. It is important for HCM patients to be carefully followed up over the long-term because HCM is a lifelong disease.Keywords
This publication has 20 references indexed in Scilit:
- Clinical Characteristics and Prognosis of End-stage Hypertrophic CardiomyopathyChinese Medical Journal, 2015
- Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management StrategiesJACC, 2015
- Clinical Characteristics and Long-Term Outcomes of Hypertrophic CardiomyopathyInternational Heart Journal, 2015
- Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: Report from the registry data in JapanJournal of Cardiology, 2013
- Patterns of Disease Progression in Hypertrophic CardiomyopathyCirculation: Heart Failure, 2012
- Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Longitudinal Observation in a Rural CommunityCirculation Journal, 2006
- Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophyJACC, 2004
- Hypertrophic cardiomyopathyThe Lancet, 2004
- Epidemiology of Hypertrophic Cardiomyopathy–Related DeathCirculation, 2000
- Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional populationJACC, 1995